Simplifying Global Compliance
FDA Seeking Stakeholder Input on Postapproval Study Designs
Devices & Diagnostics Letter
Companies could get a better idea of what the FDA expects in postapproval studies (PAS) required as part of a device’s approval at an Aug. 30 agency workshop.
To View This Article:
Subscribe To Devices & Diagnostics Letter
Buy This Article Now
Copyright ©2018. All Rights Reserved.
Design, CMS, Hosting & Web Development :: ePublishing